早产儿新型支气管肺发育不良研究进展

Abstract
Figure/Table
References (28)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Neonatal bronchopulmonary dysplasia is a chronic lung disease.With the development of medical technology,premature bronchopulmonary dysplasia has changed from classical to new.At present,the incidence of bronchopulmonary dysplasia is increasing year by year,and the smaller the gestational age,the higher the incidence of bronchopulmonary dysplasia.In this paper,we summarized the etiology,basic characteristics,diagnosis and treatment of new BPD.Focus on the pathological characteristics of the new BPD,performed animal experiments and clinical trial,which may become a hot research topic for premature infants with bronchopulmonary dysplasia.

Key words： Preterm infants Bronchopulmonary dysplasia New transformation Basic characteristics

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Yi-xin
	ZHANG Hua

Cite this article:

ZHU Yi-xin,ZHANG Hua. Progress in the study of new type of bronchopulmonary dysplasia in premature infants[J]. 中国当代医药, 2018, 25(8): 27-30.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I8/27

[1]	肖勇，黄维清.早产儿支气管肺发育不良危险因素的logistic回归分析及其意义[J].中国误诊学杂志，2010，10（36）：8829－8830.
[2]	Viscardi RM.Perinatal inflammation and lung injury[J].Semin Fetal Neonatal Med，2012，17（1）：30-35.
[4]	Alan，H.Jobe.肺发育和肺损伤-新型支气管肺发育不良[J].中国当代儿科杂志，2001，3（4）：345-347.
[3]	Northway WH Jr，Rosan RC，Porter DY.Pulmonary disease following respiratortherapy of hyaline-membrane disease：Bronchopulmonary dysplasia[J].N Engl J Med，1967，276（7）：357-368.
[5]	Bhandari A，Bhandari V.Pitfalls，problems，and progress in bronchopul-monary dysplasia[J].Pediatrics，2009，123（6）：1562-1573.
[6]	Fanaroff AA，Stoll BJ，Wright LL.Trends in neonatal morbidity and mortality for very low birthweight infants[J].Am J Obstet Gynecol，2007，196（2）：147.e1-e8.
[7]	早产儿支气管肺发育不良调查协作组.早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J].中华儿科杂志，2011，49（9）：655-662.
[8]	Wilson AC.What does imaging the chest tell us about bronchopulmonary dysplasia？[J].Paediatr Respir Rev，2010，11（3）：158-161.
[9]	常立文.新生儿支气管肺发育不良诊治进展[J].临床儿科杂志，2007，25（3）：161-165.
[10]	Abman SH.Bronchopulmonary dysplasia： “a vascularhypothesis”[J].Am J Respir Crit Care Med，2001，164 （1）：1755-1756.
[11]	Viscardi RM.Perinatal inflammation and lung injury[J].Semin Fetal Neonatal Med，2012，17（1）：30-35.
[12]	Jonsson B，Li YH，Noack G，et al.Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity[J].Acta Paediatr，2000，89（11）：1375-1380.
[13]	张华，刘漫君，全裕凤.支气管肺发育不良的分子水平及发病机制的研究进展[J].医学综述，2013，19（12）：2121-2123.
[14]	Kunig AM，Balasubramaniam V，Markham NE，et al.Recombinant human VEGF treatment enhances alveolarizationafter hyperoxic lung injury in neonatal rats[J].Am J Physiol Lung Cell Mol Physiol，2005，289（4）：L529-L535.
[15]	Rogers LK，Robbins M，Dakhlallah D，et al.Attenuation of miR-1792 cluster in bronchopulmonary dysplasia[J].Ann Am Thorac Soc，2015，12（10）：1506-1513.
[16]	Padela S，Cabacungan J，Shek S，et al.Hepatocyte growth factor is required for alveologenesis in the neonatal rat[J].Am J Respir Crit Care Med，2005，172（7）：907-914.
[17]	Miller RJ，Sullivan MC，Hawes K，et al.The effects of perinatalmorbidity and environmental factors on health status of preterm children at age12[J].J PediatrNurs，2009，24（2）：101-114.
[18]	Speer CP.Inflammation and bronchopulmonary dysplasia[J].se-min Neonatol，2003，8（1）：29-38.
[19]	Keszler M，Sant′Anna G.Mechanical ventilation and bronchopulmonary dysplasia[J].ClinPerinatol，2015，42（4）：781-96.
[20]	O′Reilly M，Theaud B.Animal models of bronch opulrr lonary dysplasia The tem rat models[J].Am J Physiol Lung Cell Mol Physiol，2014，307（12）：L948-L958.
[21]	Malpel S，Mendelsohn C，Cardoso WV.Regulation of reTinoicacid sig-naling during lung morphogenesis[J].Development，2000，127（14）：3057-3067.
[22]	LondheVA，MaisonetTM，LopezB，et al.Retinoic acid rescues alveolar hypoplasia in the calorie-restricted developing rat lung[J].Am J Respir Cell Mol Biol，2013，48（2）：179-187.
[23]	Kakavas S，Demestiha T，Vasileiou P，et al.Erythropoetin as a no-vel agent with pleiotropic effects against acute lung injury[J].Eur J Clin Pharmacol，2011，67（1）：1-9.
[24]	Lassus P，Turanlahti M，Heikkila P，et al.Pulmonary vascular endothelial growth factor and Flt-1 in fetuses，in acute and chronic lung disease，and in persistent pulmonary hypertension of the newborn[J].Am J Respir Crit Care Med，2001，164（10）：1981-1987.
[25]	Yilmaz C，Koksal N，Ozkan H，et al.Low serum IGF-1 and increased Cytokine levels in trachealaspirate samples are associated with bronchopulmonary dysplasia[J].Turk J Pediatr，2017，59（2）：122-129.
[26]	Wallace B，Peisl A，Seedorf G，et al.Anti-sFlt1 therapy preserves lung alveolar and vascular growth in antenatal models of BPD[J].Am J Respir Crit Care Med，2018，197（6）：776-787.
[27]	Syed M，Das P，Pawar A，et al.Hyperoxia causes miR-34amediated injury via angiopoietin-1 in neonatal lungs[J].Nat Commun，2017，8（1）：1173.
[28]	Cetinkaya M，Cekmez F，Erener-Ercan T，et al.Maternal/neonatal Vitamin D deficiency：a risk factor for bronchopulmonary dysplasia in preterms？ [J].J Perinatol，2015，35（10）：813-817.